Literature DB >> 9705296

Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor.

M Najimi1, F Souazé, M Méndez, E Hermans, T Berbar, W Rostène, P Forgez.   

Abstract

Neurotensin (NT) acts through specific G protein-coupled receptors to induce effects in the central nervous system and periphery. In this study we have shown that in the human neuroblastoma cell line CHP 212, an NT agonist, JMV 449, induced high affinity neurotensin receptor (NTR) gene activation. 125I-NT binding of cells challenged with JMV 449 rapidly decreased then reappeared and subsequently stabilized at 50% of the control values after 48 h of agonist exposure. These receptors, which reappeared at the cell surface, are as active as those found in control cells as demonstrated by Ca2+ mobilization. Furthermore, the tyrosine hydroxylase (TH) gene, a known NT target gene, remained activated after prolonged NT agonist exposure in this cell line. In the murine neuroblastoma cell line, N1E-115, NT did not stimulate NTR gene activation but induced NTR mRNA destabilization after long term agonist exposure. In this cell line, NT binding dropped to 15% of control values and remained at this value after agonist treatment. The TH expression, which was originally activated upon NT agonist exposure, decreased to control values after prolonged agonist exposure. These observations combined with the data obtained from a complementary study with HT-29 cells (Souazé, F., Rostène, W., and Forgez, P. (1997) J. Biol. Chem. 272, 10087-10094) revealed the crucial role of agonist-induced receptor gene transcription in the maintenance of cell sensitivity. A model for G protein-coupled receptor regulation induced by prolong and intense agonist stimulation is proposed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705296     DOI: 10.1074/jbc.273.34.21634

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.

Authors:  I Lépée-Lorgeoux; C Betancur; F Souazé; W Rostène; A Bérod; D Pélaprat
Journal:  J Neurosci Res       Date:  2000-05-01       Impact factor: 4.164

2.  Transcriptional regulation of the tyrosine hydroxylase gene by neurotensin in human neuroblastoma CHP212 cells.

Authors:  M Najimi; E Hermans; W Rostène; P Forgez
Journal:  Metab Brain Dis       Date:  2001-12       Impact factor: 3.584

3.  Endogenous CNS expression of neurotensin and neurotensin receptors is altered during the postpartum period in outbred mice.

Authors:  Terri M Driessen; Changjiu Zhao; Anna Whittlinger; Horecia Williams; Stephen C Gammie
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

4.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

5.  Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.

Authors:  Mohamad Younes; Zherui Wu; Sandra Dupouy; Audrey Mansuet Lupo; Najat Mourra; Takashi Takahashi; Jean François Fléjou; Jean Trédaniel; Jean François Régnard; Diane Damotte; Marco Alifano; Patricia Forgez
Journal:  Oncotarget       Date:  2014-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.